Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Tel-Aviv Sourasky Medical Center Enzymotec |
---|---|
Information provided by: | Tel-Aviv Sourasky Medical Center |
ClinicalTrials.gov Identifier: | NCT00719953 |
A Single-Center, Open Label Study to Assess the Efficacy of Cognitex in Elderly Subjects with Memory Impairment
Condition | Intervention | Phase |
---|---|---|
Elderly Memory Impairment |
Dietary Supplement: Cognitex |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Single Group Assignment, Efficacy Study |
Official Title: | A Single-Center, Open-Label Study to Assess the Efficacy of Cognitex in Elderly Subjects With Memory Impairment |
Estimated Enrollment: | 30 |
Study Start Date: | August 2008 |
Estimated Study Completion Date: | August 2009 |
Estimated Primary Completion Date: | August 2009 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 60 Years to 90 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Israel | |
Suorasky Medical Center | |
Tel-Aviv, Israel |
Principal Investigator: | Nachum Vaisman, Prof' | Tel-Aviv Sourasky Medical Center, Israel |
Responsible Party: | Enzymotec Ltd. ( Yael Richter. Project Manager ) |
Study ID Numbers: | TASMC-08-NV-305-CTIL, 0305-08-TLV |
Study First Received: | July 21, 2008 |
Last Updated: | December 18, 2008 |
ClinicalTrials.gov Identifier: | NCT00719953 |
Health Authority: | Israel: Ministry of Health |
Cognitex subjects |
Signs and Symptoms Neurologic Manifestations Neurobehavioral Manifestations Memory Disorders |
Nervous System Diseases |